In the last decade, multiple studies have investigated the genetic susceptibility for ADHD, most notably including assessment of enrichment of copy number variation[@b1][@b2][@b3][@b4][@b5][@b6][@b7]. Genome-wide association studies (GWAS) of single nucleotide variants (SNVs) in ADHD have also been executed and a few variants of small or moderate effect sizes have been reported[@b3][@b8][@b9]. Despite these promising results, genes identified by GWAS (capturing CNVs and SNVs) still only contribute for a small percentage of the heritability of this complex trait[@b10] and replication across these studies has been inconsistent[@b11]. This is likely attributed to the combination of modest effect sizes of causative mutations on disease susceptibility and underpowered studies due to small sample sizes. Meta-analyses in ADHD, while theoretically more powerful, has not succeeded in discovering novel loci[@b7]. However, copy-number variation (CNVs) analysis has been more successful than SNV analysis[@b1][@b2][@b4][@b5][@b12][@b13][@b14][@b15].

Extensive literature has also emerged from the integration of different databases to prioritize variants of biological interest involving complex diseases such as psychiatric disorders[@b16][@b17][@b18][@b19][@b20]. In this regards, the public database ADHDgene (<http://adhd.psych.ac.cn/>) and reported a candidate ADHD gene list based on the overlap of five prioritization gene tools. Poelmans *et al*.[@b19] used the results from five previous GWAS in ADHD to search for biological functions and pathways with the objective of reanalyze the results together. They performed a systematic literature searches for (putative) functions of the proteins coded by 85 consensus genes from GWAS.

Protein-protein interaction networks have more recently been shown to be of added value in: identifying new disease genes, studying their network properties, identifying disease-related sub-networks, and network-based disease classification[@b21]. The foundation for using data integration based on protein-protein interactions (PPI) data relies on the hypothesis that proteins related to the same diseases or phenotypes tend to interact or are closely located in the network[@b22][@b23]. Approaches using GWAS data and PPI networks have been published with focus on psychiatric disorders, including bipolar disorder[@b16], schizophrenia[@b17], autism[@b18], as well as ADHD[@b1][@b14]. Elia and colleagues[@b1] used PPI data to investigate networks with genes overrepresented in CNVs affecting multiple cohorts. They reported that CNVs in glutamate receptor family genes and in genes interacting with them were enriched in approximately 10% of cases, showing for the first time association of glutamate receptor genes with ADHD.

With the development of new genomic techniques to investigate changes in DNA, it has been possible to discover the genetic causes for a larger range of conditions and phenotypes than ever before. For some complex disorders, it has been necessary to apply methods to analyze genome-wide variants with SNP arrays in conjunction with sequencing data to combine both common and rare variants[@b24][@b25][@b26]. Analysis of high throughput sequencing data has been successful in covering genomic regions with low frequency mutations, which also have impact in complex diseases[@b14][@b25]. Moreover different types of very rare variants, such as *de novo* variants, compound heterozygosity and even heritable heterozygous missense variations have been shown to contribute to neurodevelopment disorders[@b27][@b28].

In other complex psychiatric disorders, such as autism[@b29][@b30][@b31] and schizophrenia[@b32][@b33], the role of common or inherited variants has been shown to be important. Small CNVs have also been reported[@b34][@b35]. These studies show that the genetic landscape of neurodevelopment psychiatric disorders can be composed by the combination of different types of variants.

According to Hawi *et al*.[@b36], "As with other psychiatric disorders, the monogenic concept of ADHD has now been supplanted by a more plausible polygenic hypothesis where multiple risk genes (each of minor/modest effect) contribute to the etiology of the disorder. As detailed previously, ADHD-associated genes (and those showing trends towards association) are scattered through the genome but tend to be enriched within specific functional categories. This suggests that the emphasis on any individual candidate gene should be shifted to consider a broader network view of biological pathways involving ADHD-implicated genes."

As previously proposed by Girirajan and Eichler[@b37], we have used in this present study both *de novo* and inherited variants to integrate our model of ADHD genetic architecture using an exome analysis of 30 sporadic ADHD Brazilian trios and SNP-array from 503 typically Brazilian developed children. To validate our findings we integrated our results with public ADHD genetic resources, gene expression data bases and PPI databases exploring the ADHD network in accordance to Hawi *et al*.[@b36] and the hypothesis of network medicine described by Barabasi *et al*.[@b22], that genes related to the same disease tend to interact.

Methods
=======

In all analyses we only accepted variations in genes expressed in brain based on data from the Brain Span Atlas of the Developing Human Brain (<http://brainspan.org>), Brain Atlas (<http://human.brain-map.org>) and GTEx Portal (<http://gtexportal.org>). The analyses were conducted in 3 steps:we used only data from Brazilian samples, searching for *de novo* and inherited SNVs and CNVs comparing ADHD trios and control samples to better explore the genomic architecture of our ADHD samples.we constructed a protein-protein interaction network (PPI) based on all genes with SNVs and CNVs findings by our work and studies with samples of children and adolescents reported by ADHDgene database (<http://adhd.psych.ac.cn>) and explore functional annotation of the network as well as topological properties of ADHD genes in the PPI network.to achieve a highly reproducible ADHD gene set we selected only genes with two evidences: presented in our SNV and CNV analyses in different families or presented in our analyses and also in a previous GWAS or CNV public ADHD analyses. We used this gene set as seeds to growth a PPI.

A summary of steps 1 and 2 can be found in [Fig. 1](#f1){ref-type="fig"}.

Brain expression data
---------------------

The samples from Brain Span Atlas of the Developing Human Brain (<http://brainspan.org>), Allen Human Brain Atlas (<http://human.brain-map.org>) and GTEx Portal (<http://www.gtexportal.org>) were used to understand what genes are expressed in brain. Genes with 1 *reads per kilobase per million reads* (RPKM) in any area of the brain in at least one sample were considered expressed. After evaluation, our list contained 54141 transcripts.

STEP 1 - Brazilian samples

The sample is part of the High Risk Cohort Study for Psychiatric Disorders in Childhood[@b38], a two-stage large community study of children aged 6 to 12 years (at screening) from 57 schools in two Brazilian cities - Porto Alegre (n = 22) and São Paulo (n = 35). The ethics committee of the University of São Paulo approved the study and written consent from parents of all participants were collected. Detailed data could be found in Salum *et al*.[@b38]. Briefly, during the screening phase at their school registry day, 9,937 informants were interviewed. Two subgroups using a random-selection (n = 958) and high-risk group (n = 1,514) selection procedure that consisted of selecting individuals with high family loading of symptoms and ongoing psychiatric symptoms, were recruited resulting in a total sample of 2,512. Saliva was collected from all subjects and their parents. To establish child psychiatric diagnoses, the parent-reports of the Brazilian Portuguese version of the Development and Well-Being Assessment -- DAWBA was performed by trained psychiatrists and to assess parent psychiatric diagnoses the Mini International Psychiatric Interview (MINI) and MINI Plus were used. Out of 2,512 subjects 240 met DAWBA criteria for any ADHD, being 66 from the randomly selected group and 240 from the high-risk group. For the exome analysis, we selected 35 trios, in which the child was affected by ADHD and the parents were healthy as well as no familial history of ADHD was reported in the screening interview. A sub-sample of 724 subjects out of the 2,512 was selected to collect blood and perform a functional magnetic resonance imaging (fMRI) study[@b39]. We used 503 subjects from this sub-sample, in which the child was not affected by any DAWBA diagnosis and has available genotypes after quality control criteria using an SNP-array platform assay.

Exome data processing of Brazilian samples
------------------------------------------

The Nextera^®^ Exome Enrichment Kit (Illumina Inc., San Diego, USA) was utilized to construct the libraries, which were prepared over a target region of 62 Mb, 20,794 genes, 201,121 exons. The sequencing was performed using two technologies. In eight trios, Illumina HiScan SQ™ (Illumina, Inc.) was utilized. In 27 other trios, HiSeq 2500™ (Illumina, Inc.) was utilized. The reads were sequenced with the paired-end technique, producing in average 24 million reads per sample with length of 100bp, resulting in 2.4Gb sequenced per sample. The reads were mapped to *National Center for Biotechnology Information* (NCBI) *reference human genome build* 37 (GRCh37/hg19), using the software Burrows-Wheeler Aligner, or BWA (<http://bio-bwa.sourceforge.net>). These mapped reads were the input for Picard (<http://broadinstitute.github.io/picard>) and GATK Unified Genotyper (<https://www.broadinstitute.org/gatk>) to find single-nucleotide variants through the best practices pipeline (<https://www.broadinstitute.org/gatk/guide/best-practices>) and calculate the exons coverage to run the program to identify CNVs. We used the software KING (<http://people.virginia.edu/~wc9c/KING>) to check kinships between parents and children. It is expected that the value of the kinship between one parent and one child must be between 0.17 and 0.35. If the kinship is much lower than this value, it means that there is no relation of parenthood or that the samples might be contaminated. Trios with at least one kinship relation below 0.19 were removed from our analyses.

Single-nucleotide variant (SNV) analysis in exome of Brazilian cases
--------------------------------------------------------------------

Variants were annotated using Annovar (<http://annovar.openbioinformatics.org>) and SnpEff (<http://snpeff.sourceforge.net>), and databases dbSNP build 137 (<http://www.ncbi.nlm.nih.gov/SNP/>). We called 'common' the variants with maximum value minor allele frequency (MAF) greater than 5% in the ExAC database (<http://exac.broadinstitute.org>). Variants with at maximum MAF between 1% and 5% were called 'rare', 'very rare' if the maximum MAF was less than 1% and 'novel' if the variant was not found in the databases. After the annotation, we looked for three types of SNVs that could contribute to the disease: 1. *de novo* mutations with moderate and high impact (missense, nonsense or splice site); 2. rare, moderate impact (missense) homozygous mutations for loci where both parents are heterozygous; and 3. very rare, high impact (nonsense and splice site) heterozygous mutations.

Copy-number variant (CNV) analysis in SNP array data of Brazilian healthy children
----------------------------------------------------------------------------------

The samples were genotyped in HumanCore-12 v1.0 BeadChip (Illumina, Inc.), with 298,930 SNPs. We used PennCNV[@b40] to detect the CNVs in Brazilian control samples.

Copy-number variant (CNV) analysis in exome of Brazilian cases
--------------------------------------------------------------

We used XHMM (<http://atgu.mgh.harvard.edu/xhmm>) to find copy-number variants in exome sequencing data. We selected only CNVs with at least 3 exons, minimum of 1kb, phred-scaled qualities of some CNV event in the interval and the quality of the region not being diploid were at least 90 and that were not present in Brazilian controls (SNP arrays data). We considered false positive and removed from the analysis CNVs present in more than three healthy parents, deletions with heterozygous SNVs rate above 10%, and duplications with average B allele frequency[@b40] between 0.4 and 0.6.

STEP 2 --Integration of Brazilian data with public databases and ADHD PPI network construction.

Single-nucleotide polymorphisms in public data
----------------------------------------------

We used the set of genes related to the 50 resulting SNPs with P-value ≤ 10^−5^ from Neale *et al*.[@b7] meta-analysis. This meta-analysis included only studies with children/adolescents and with the same categorical diagnostic variables, which decreases chances of phenotypic heterogeneity. All genes expressed in brain inside the CNV regions were considered.

Copy-number variants in public data
-----------------------------------

We also used the CNV studies from predominantly Caucasian samples of children/adolescents reported in the ADHDgene database. They are part of the following publications: Williams *et al*.[@b5] (57 CNVs reported), Lesch *et al*.[@b2] (17 CNVs reported), Lionel *et al*.[@b4] (23 CNVs reported), Elia *et al*.[@b1] (19 CNVs reported) and Jarick *et al*.[@b15] (1 CNV reported). From the regions reported by these studies, we searched for genes that had an overlap with these regions, using package *biomaRt* (<http://bioconductor.org/packages/biomaRt>). We converted all the regions to hg19 (version 19 of the human genome reference) positions using the package *rtracklayer* (<http://bioconductor.org/packages/rtracklayer>) of R language, which uses the same algorithm of UCSC genome browser (<http://genome.ucsc.edu/cgi-bin/hgLiftOver>). All genes expressed in brain inside the CNV regions were considered.

Protein-protein interaction data
--------------------------------

To construct the PPI networks, we used the data from iRefIndex compilation (<http://irefindex.org>). This database is a union of the main PPI databases: BIND (<http://bind.ca>), BioGRID (<http://thebiogrid.org>), CORUM (<http://mips.helmholtz-muenchen.de/genre/proj/corum>), DIP (<http://dip.doe-mbi.ucla.edu>), HPRD (<http://hprd.org>), IntAct (<http://www.ebi.ac.uk/intact>), MINT (<http://mint.bio.uniroma2.it/mint>), MPPI (<http://mips.helmholtz-muenchen.de/proj/ppi>)and OPHID (<http://ophid.utoronto.ca>). We selected only links supported by at least two pieces of direct experimental evidence demonstrating physical interaction between each pair of human proteins. The network was treated as an undirected graph. This final network has 73911 edges, representing protein-protein interactions, and 12464 nodes, representing genes/proteins.

Network measures
----------------

In order to analyze the nodes and topological features, centrality measures (brokering centrality and betweenness centrality) and clustering coefficients were calculated[@b41]. The degree is the number of links of a node with other nodes (called neighbors) in the network. Nodes with very high degree are called hubs since they are connected to many neighbors. The removal of such nodes has great impact on the network topology. It has been shown that biological networks tend to be robust against random perturbations, but disruption of hubs often leads to system failure. In this work, a measure called brokering centrality[@b41] was used to identify hubs whose neighbors do not connect each other (or they connect less than expected). This measure uses the degree and the clustering coefficient to be calculated. The betweenness centrality is the measure of how a node is in the center of the network, and it shows important nodes that lie on a high proportion of paths between other nodes in the network. Proteins with high betweenness centrality have been termed "bottlenecks", for their role as key connectors of proteins with essential functional and dynamic properties[@b22]. For a review of formulas of all these measures, see Cai *et al*.[@b41]. To compute nodes/genes measures, it was used the Python library NetworkX (<http://networkx.github.io>). We calculated such measures for all the nodes in the network and classified the top 5% ranked for each measure as, respectively, brokers or bottlenecks.

Analysis of overrepresented pathways, biological functions, cytogenetic bands and diseases associated to the different sets of genes
------------------------------------------------------------------------------------------------------------------------------------

To perform the enrichment analyses, the tool WebGestalt (<http://bioinfo.vanderbilt.edu/webgestalt>) was utilized. In this program, the set of genes in the human genome was used as reference, the corrections were made using Benjamini and Hochberg method, and only the top 10 terms with an adjusted P-value less than 0.05 were considered significant for our analysis. For KEGG analysis, we used the program STRING (<http://string.embl.de>), because the version was more updated (2014) than WebGestalt for KEGG (2011). For STRING, the Bonferroni correction was utilized in the adjustment.

STEP 3 -- To achieve a highly reproducible ADHD gene set we selected only genes harboring probably deleterious variations presented by at least two evidences: presented in Brazilian SNV and CNV analyses of two different families or presented in our analyses and also in a previous public analyses. Using only directed interaction to growth the seed genes considered highly reproducible we use the iRefIndex database (<http://irefindex.org>), to construct a PPI network and explore functional ontology of the network as already described above.

Results
=======

Psychiatric disorders are considered polygenic and multifactorial, so today it is clear that both rare and common variation contribute to the genetic architecture of such diseases. In addition, it is also known that individuals from different families could have different variations for the same diseases[@b42]. For these reasons, stringent analysis criteria have been used, as comparison with public databases in the gene level, not in the variant level. On the other hand, various disorders hare the same genes, and one gene could participate in different processes, which leads us to believe that we should look at such diseases in a systemic view. One way to investigate it is by searching for biological networks and its topological properties, like clusters of genes and their biological functions, which could better explain genetic mechanisms of predisposition for a range of diseases or even for a specific disease. Following this idea, to prioritize genes and networks related to ADHD we present our results in three steps:Analysis of individual variations in a specific population (SNV and CNV of Brazilian samples);Integration of our data with public data in a gene level and analysis of such data in a systems biology approach, using protein-protein interaction networks of genes expressed in brain (Integrated PPI ADHD network);Finding a highly reproducible ADHD gene set and the ADHD network.

To have a high reliability in each of these steps, the following criteria detailed in the method section were used:

In the first one we describe our exome results of 30 trios using high stringent criteria to variant call: target coverage of 45× (average) and 50% of target regions with at least 20× of coverage. We removed trios with bad overall mapping quality and low values of kinship. Regarding overall single-nucleotide variants (SNVs), we removed variants with less than 10 read depth or genes not expressed in brain. More specifically for *de novo* SNVs, we selected only moderate to high impact (nonsense, missense or splice site) SNVs. For copy-number variants (CNVs), we used an independent sample of healthy Brazilian children/adolescents and removed any CNVs also found in this sample. Besides applying the best practices of XHMM (a reliable software for CNV calling in exoma data)[@b43], we developed a new method for removing false positive CNVs taking into account single-nucleotide variants (SNVs) for both deletions and duplications. Our method, inspired by PennCNV[@b40] algorithm, performs a post-processing analysis checking the allele frequencies of SNVs in each CNV to remove those with a large difference of expected proportions.

In the second part we used data from public GWAS data exactly to find more confident results. Up to date, none of the previous GWAS studies performed in children and adolescents with ADHD was able to reach statistical significance in genomic level. Although no variant reached significance, some findings show that common and rare variants could contribute to the disease. Given that, we decided to integrate our exome data results and public datasets of main genetic studies -- including 50 SNPs from Neale *et al*.[@b7] meta-analysis with P-value ≤ 10^−5^, and four studies that reported validated CNVs[@b1][@b2][@b4][@b5] -- all performed with children/adolescents having ADHD. Genes with no expression in brain, according to GTEx database, were removed.

In the third step, to achieve a highly reproducible ADHD gene set we selected only genes harboring probably deleterious variations presented by at least two evidences: presented in Brazilian SNV and CNV analyses of two different families or presented in our analyses and also in a previous public analyses. Using only directed interaction to growth the seed genes considered highly reproducible we use the iRefIndex database (<http://irefindex.org>), to construct a PPI network and explore functional ontology of the network as already described above.

1\. Analysis of individual variations in a specific population (SNV and CNV in Brazilian samples).

Single-nucleotide variants (SNV) analysis in the exome of Brazilian samples
---------------------------------------------------------------------------

Five trios were excluded from the analysis: one because the father sample did not pass the quality criteria of the sequencing pipeline, 3 trios because at least one kinship factor was less than 0.17 and one trio because both kinship factors were exactly at 0.17. Thirty trios remained in the analysis. We looked for three types of single-nucleotide variants that can be contributing to the disease:*De novo* mutations with moderate and high impact (missense, nonsense or splice site): 26 variants were found in 25 genes, and all of them are expressed in brain ([Table 1](#t1){ref-type="table"}). In the gene *VWDE* two variants were found in the same family. One cytogenetic band presented hits in three different families: 19p13 (size: 20 Mb).Very rare, high impact (nonsense and splice site) heterozygous mutations ([Sup. Table 2](#S1){ref-type="supplementary-material"}): 134 different variants were found in 134 genes expressed in brain. Six out of these 134 genes presented the same variant in two families*: ACOXL, ANKRD42, CYFIP2, MSR1, NPSR1, OBSL1.* The other 128 genes presented only one variant. Five cytogenetic bands presented hits in at least 4families: 3q13 (size: 89.7Mb), 5q33 (size: 10.1 Mb), 11p15 (size: 21.7 Mb), and 19p13 (size: 20 Mb); and 19q13 (size: 26.7 Mb) presented hits in 10 families.Rare, moderate impact (missense) homozygous mutations for loci where both parents are heterozygous: 127 different variants were found in 120 genes expressed in brain. Five genes *(ACSM1, GIMAP6, ILDR1, MUC6, RGS12)* presented two variants in the same family, one gene *(IFLTD1)* presented three variants in the same family and one gene presented *(DNAH3)* the same variant in two different families. The other 113 genes presented only one variant. Two cytogenetic bands presented hits in 4 different families: 1p36 (size: 28 Mb) and 19q13 (size: 26.7 Mb). The other results are detailed in [Sup. Table 3](#S1){ref-type="supplementary-material"}.

Copy-number variant (CNV) analysis in the exome of Brazilian samples
--------------------------------------------------------------------

After mapping the reads to the Human genome (GRCh37/hg19), we used the XHMM software to call copy-number variations (CNVs). We found 13occurrences of putative CNVs in the Brazilian children, three being *de novo* CNVs, seven inherited exclusively from father and three inherited exclusively from mother. In these regions, 22 genes were found to be expressed in brain. The [Sup. Table 1](#S1){ref-type="supplementary-material"} has all CNVs found in the 30 trios. The gene TRIM48 (11q11) was found in a *de novo* and in an inherited CNV in two different children. We used the software BEDTools (<http://bedtools.readthedocs.org>) to find the overlap and calculate the distances between CNV regions.

Analysis of SNVs and CNVs in the Brazilian trios
------------------------------------------------

To investigate how inherited and *de novo* variants were distributed in the Brazilian children, we merged inherited SNVs and CNVs and compared it with *de novo* SNVs and *de novo* CNVs ([Fig. 2](#f2){ref-type="fig"}). It is interesting to note that although our sample size is small we could observe that in average, children with only inherited variants, when compared to children with *de novo* variants, have two times more comorbidities. This is shown with more details in [Sup. Table 4](#S1){ref-type="supplementary-material"}.

2\. Integration of our data with public data in a gene level and analysis of such data in a systems biology approach, using protein-protein interaction networks of genes expressed in brain (Integrated PPI ADHD network).

Taking into account all the genes reported with SNP or in CNV in public databases or genes with SNV or in CNV in the Brazilian data, we ended up with a set of 1128 genes expressed in brain. We removed the olfactory receptors (total = 80) to avoid bias in the functional analysis. The final set has 1048 genes.

The GO analysis of these genes showed significant results for molecular function "ligand-gated ion channel activity" (GO:0015276), with 18 genes and adjusted P-value of 0.0093. The KEGG analysis showed significant results for "Neuroactive ligand-receptor interaction" (22 genes, adj. P-value = 9.63e--05), "Metabolic pathways" (50 genes, adj. P-value = 0.0015), "Calcium signaling pathway" (14 genes, adj. P-value = 0.0025), "Tight junction" (12 genes, adj. P-value = 0.0025), "Ubiquitin mediated proteolysis" (12 genes, adj. P-value = 0.0025), "Adherens junction" (8 genes, adj. P-value = 0.0056), "Cytokine-cytokine receptor interaction" (15 genes, adj. P-value = 0.0238). The cytogenetic bands significantly associated with ADHD were 15q11 (88 genes, adj. P-value = 1.30e--87, size = 6.7 Mb), 16p11 (70 genes, adj. P-value = 6.82e--55, size = 8.5 Mb), 7p15 (20 genes, adj. P-value = 8.26e--12, size = 7.9 Mb), 11q25 (10 genes, adj. P-value = 3.86e--08, size = 4.2 Mb), 4p15 (15 genes, adj. P-value = 6.02e--08, size = 24.5 Mb), 15q12 (20 genes, adj. P-value = 2.69e--07, size = 2.4 Mb), 20p13 (15 genes, adj. P-value = 3.22e--07, size = 5.1 Mb) and 8q21 (16 genes, adj. P-value = 4.08e--07, size = 49.8 Mb).

To study how the genes were relatively located in the network space, we plotted a network with the genes related to ADHD and their direct interactions using protein-protein interaction databases. This network is composed only of genes expressed in brain. Out of 1128 genes, only 557 were mapped in the interactome. Besides the 557 seed genes, 2240 more genes were added to the network. The network is shown on [Fig. 3](#f3){ref-type="fig"}.

3\. Finding a highly reproducible ADHD gene set and the ADHD network.

To obtain a more robust view of the genes with SNVs and/or in CNVs, we selected genes with variants found in both the Brazilian exome data and public ADHD CNV data. [Table 2](#t2){ref-type="table"} includes these 30 of the most significant and informative genes and which type of analyses they were derived from. All the other genes resulted from a single analysis.

Using only these 30 genes as seeds, we built a subnetwork adding the direct interactions to analyze which biological functions were associated with these genes. Out of 30 genes, only 15 were in the interactome. The final network ended up having 101 genes ([Fig. 4](#f4){ref-type="fig"}). Using WebGestalt, we found gene ontology categories and protein modules over-represented in this network. Regarding cellular components, there are 13 genes related to neuron projection (adj. P-value = 6.00e--04), 5 genes related to cell-substrate adherens junction (adj. P-value = 3.00e--03), 34 genes related to membrane-enclosed lumen (adj. P-value = 1.60e--03) and 14 genes related to synapse (adj. P-value = 7.80e--05). Moreover, the central nervous system genes are significantly connected in the network, according to WebGestalt analysis of protein modules (adj. P-value = 3.02e--05). Using STRING, we performed the enrichment analysis for KEGG and obtained the more specific synapse results: glutamatergic synapse (7 genes, adj. P-value = 3.28e--04) and serotoninergic synapse (6 genes, adj. P-value = 4.81e--03). This is shown in [Table 3](#t3){ref-type="table"}.

Discussion
==========

Despite a 70% to 80% heritability estimate[@b44], finding gene variants associated with the ADHD phenotype has been extremely challenging. Some genes seem to be more related to the susceptibility of any psychiatric neurodevelopmental disorder but the complexity of combinations of non-specific variations with more individual ones and the environment will bring the colors of a specific disorder[@b45]. With this idea, we explored different types of genetic variations using ADHD trios exome data. An intuitive method to find variations related to a disorder is to look for *de novo* variants in trios where the parents do not have ADHD and the children show the phenotype. Such variants have been shown as potential causes of several psychiatric diseases[@b12][@b13][@b34][@b46]. Here we found 26 *de novo* SNVs with moderate and high impact in 25 brain-expressed genes in 14 different families and three *de novo* CNVs in different families. Although combining exome and GWAS studies has some technical limitations, studies in the literature have demonstrated the effectiveness of using combined analysis methods[@b47]. To search CNVs related to ADHD, it is important to mention that we compared in this present study the copy-number variants found in the Brazilian trios using whole-exome data combined with CNV regions found in 503 Brazilian controls using SNP-array data. The intention was to remove any CNVs that are present in controls from the analysis.

However, it also has been shown that rare inherited variants[@b35] play an important role in other neurodevelopment disorders[@b37]. Assuming that ADHD should not be different from other neurodevelopmental disorders, we searched for inherited SNVs and CNVs. Regarding SNVs, we found 127 rare, moderate impact (missense) homozygous mutations for loci where both parents are heterozygous in 120 reported genes expressed in brain, suggesting a possible recessive heritability in ADHD as has been suggested for autism[@b48]. Besides that, 134 very rare, high impact (nonsense and splice site) heterozygous mutations were found in 134 genes expressed in brain. Regarding structural variants, we found 10inherited CNVs that were not present in Brazilian controls. Although we found putative CNVs inherited more from father than from mother, the limitation of our small sample size makes difficult to assert that this is a recurring pattern.

Regarding the variants found only in the Brazilian cases, it was observed that usually it was necessary the combination of exclusively inherited variants or inherited variants with a few *de novo* variants. Interestingly, the children who presented *de novo* SNVs did not present *de novo* CNVs, and vice-versa (only one child is an exception, with one *de novo* CNV and one *de novo* SNV). This corroborates what has been shown in other psychiatric diseases[@b37], such as autism[@b29][@b30][@b31], schizophrenia[@b32][@b33], and bipolar disorder[@b49]. In these diseases, the studies reported the role of *de novo* and inherited variants, as well as common and rare variants. Particularly in ADHD, Yang and colleagues[@b14] performed a case-control analysis using SNP-array approach (Affymetrix 6.0) of a large cohort of Chinese subjects aiming to discover both common and rare variants associated with ADHD. Although they did not find genome-wide significant results, they could point some biological pathways using network analysis integrating the genes with higher association. More recently, Martin and colleagues[@b50] used UK-based children samples to test whether children with ADHD with large rare CNVs had different polygenic risk scores (based on SNPs) for ADHD when compared to children with ADHD without these CNVs. In other words, their results implied that comparing children with a large, rare CNV with children without, the former require less of a polygenic burden to develop the disease, when we look at the SNPs in these children. However, our exome data made possible to look at smaller CNVs, and we also found CNVs with less than 100kb that could be playing a role in the disease.

When we combined the variants found in CNVs or SNVs taking into account the findings in our exome data and in the public databases of children with ADHD, the results highlighted interesting biological functions and diseases significantly associated to ADHD. For example, the GO molecular function and KEGG exhibited terms related to activity of cells in brain, as "ligand-gated ion channel activity", of which some genes have been studied as therapeutic targets for ADHD, Alzheimer's disease, schizophrenia, depression and tobacco addiction. Other pathways found have already been related to ADHD. The most significant were "Neuroactive ligand-receptor interaction" (the ADHDgene database reports 89 genes), "Calcium signaling pathway" (66 genes on ADHDgene) and "Cytokine-cytokine receptor interaction". So far genes involved in synaptogenesis and calcium channels have been consistently described in the literature[@b51][@b52]. Some of the chromosome regions overrepresented have been described, but only region 11q25 were in the top regions on ADHDgene database suggesting that our network analysis could be contributing with new candidate genes related to ADHD. More interesting in the network analyses, is the topological properties of ADHD genes. Cai and colleagues[@b41] revealed that genes related to diseases tend to be brokers, and this property keeps robust even with the literature bias present in the interactome. Further studies revealed that gene properties in a network are different in autosomal or complex disorders and also that different kinds of genetic variation are related to specific topological areas of the network[@b22]. It is interesting to observe that the nodes related to ADHD SNVs or CNVs are not central or highly connected as expected for a complex disease. Although they are linked to such nodes, they are located in the borders of the network. This fact supports that the impact of such variants, separately, is not severe. In contrast, it is necessary a combination of factors to trigger the development of the disease. Together with their interactions, the genes with SNVs or in CNVs make complexes related to important biological functions.

Promising results came up when only genes recurrent in at least two different analyses and their direct interactions on PPI databases have been used, since the connections in the neighborhood of these genes could show pathways with more confidence. Some of our seed genes have already been associated with other neurodevelopmental disorders such as schizophrenia and autism. It is important to note that *Cytoplasmic FMR1-interacting protein 2 (CYFIP2)* was identified as an interaction of *FMRP*, clearly related to Autism. Importantly, CYFIP2 is a component of WAVE regulatory complex, a key regulator of actin cytoskeleton. Han and colleagues[@b53] showed that CYFIP2 could be implicated in the dendritic spine regulation in cortical neurons and suggest that misregulation of CYFIP2 function and its mGluR-induced expression contribute to the neurobehavioral phenotypes of FXS. OBSL1 is important for the regulation of a signaling mechanism that orchestrates the morphogenesis of the Golgi apparatus and pattern of dendrites[@b54]. Interestingly *NPSR1* and *UQCRC2* seem to be more specific for ADHD. NPSR1 modulated by calcium signaling pathways has been involved in Modulation of prefrontal functioning in attention systems and motor impairments[@b55] and UQCRC2 has been related to methylphenidate treatment[@b56].

Yang and colleagues[@b14] also combined CNVs and SNPs to study ADHD. Their study, which also used networks to investigate the role of different types of variants, reported synapse (15 genes) and neuron projection (16 genes) as GO (Cellular component) terms associated with regulatory regions. Interestingly, although we confirmed these categories, the overlap of genes is very low -- only gene *CNTN2* is in both analyses. Analyzing the enriched pathways, we found genes significantly related to "glutamatergic synapse", as well as "Serotonergic synapse". Elia and colleagues[@b1] reported networks with genes related to glutamatergic neurotransmission that were affected by CNVs in multiple cohorts. These findings were replicated by Akutagava-Martins and colleagues[@b57] in Brazilian samples, which supports the role of glutamate in ADHD. Regarding the glutamatergic pathway genes, our approach also discovered genes not reported by these previous studies in ADHD: PLCB1, PLCB3, GNAI2, GNAI3 and CACNA1A.

In addition to the small sample size, as a limitation of our study, admixed population such as the one from Brazil brings some particularities to the analyses[@b58]. In this scenario we used as much data integration as possible. Albeit our results confirm the disruption of pathways already associated to ADHD, it also confirms the complexity and heterogeneity of the disease, showing that in different patients, families or populations, disruption in different genes can be conducing to the development of the disease.

In conclusion, using an innovative data integration using public data and the first exome analysis performed in sporadic ADHD trios, we found other genes related to biological pathways previously reported in literature. Although our results confirmed findings published by other research groups, further analyses are essential to confirm the hypotheses and biological functions in larger and different populations. The analyses made exclusively with exome data showed a balance in inherited and *de novo* events, separating in three groups probands without any *de novo* variant, probands with *de novo* CNVs and those who had *de novo* SNVs, and also from children only with inherited variants. This could confirm the role of such variations in ADHD, but further work is necessary to find answers in non-coding regions/regulatory elements in the human genome, as well as the genes in the PPI network affect the processes involved in the disease.
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![Network created with genes related with ADHD and the direct neighbor protein on PPI databases.\
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###### The 26 *de novo* single-nucleotide variants found in the trios exome sequencing data.

  chr       pos         rsID         band                      gene                           impact           family   frequency
  ----- ----------- ------------- ---------- ---------------------------------------- ----------------------- -------- -----------
  1       2494330     rs2234167    1p36.32                   TNFRSF14                  NON SYNONYMOUS CODING   NN2624    common
  1      41296828    rs34287852     1p34.2                    KCNQ4                    NON SYNONYMOUS CODING   NN2901    common
  2      233537125   rs11550699     2q37.1                    EFHD1                    NON SYNONYMOUS CODING   NN3752    common
  3      193380726   rs200412464     3q29                      OPA1                    NON SYNONYMOUS CODING   NN3506   very rare
  4      169195114        .         4q32.3                    DDX60                    NON SYNONYMOUS CODING   NN3506     novel
  5       825280      rs1809008    5p15.33                   ZDHHC11                   NON SYNONYMOUS CODING   NN1075    common
  7      12409263    rs17165906     7p21.3                     VWDE                    NON SYNONYMOUS CODING   NN2624    common
  7      12409327    rs17165910     7p21.3                     VWDE                    NON SYNONYMOUS CODING   NN2624    common
  7      73969541     rs2301895    7q11.23                   GTF2IRD1                  NON SYNONYMOUS CODING   1659F     common
  9      87338590         .        9q21.33                    NTRK2                    NON SYNONYMOUS CODING   NN3506     novel
  9      101831995     rs10519     9q22.33                   COL15A1                   NON SYNONYMOUS CODING   1013F     common
  9      133577672        .        9q34.12                    EXOSC2                   NON SYNONYMOUS CODING   NN3506     novel
  9      139694569    rs7859194     9q34.3                   KIAA1984                  NON SYNONYMOUS CODING   1350F     common
  13     52544805     rs1801244    13q14.3                    ATP7B                    NON SYNONYMOUS CODING   NN2624    common
  14     20249176     rs2815960    14q11.2                    OR4M1                    NON SYNONYMOUS CODING   1802F     common
  14     24629768         .         14q12                     RNF31                    NON SYNONYMOUS CODING   1013F      novel
  14     25043951    rs61737120     14q12                      CTSG                    NON SYNONYMOUS CODING    691F      rare
  14     102391577    rs3742424    14q32.31                  PPP2R5C                   NON SYNONYMOUS CODING   1732F     common
  15     90818469    rs12595409    15q26.1    NGRN (dist:3026) DQ582071 (dist:18035)        STOP GAINED        NN3506    common
  17      7329310         .        17p13.1                   C17orf74                  SPLICE SITE ACCEPTOR    1372F      novel
  17     11784614         .         17p12                     DNAH9                    NON SYNONYMOUS CODING   1659F      novel
  18     61323012     rs3180227    18q21.33                  SERPINB3                  NON SYNONYMOUS CODING    894F     common
  18     61570529      rs6104      18q21.33                  SERPINB2                  NON SYNONYMOUS CODING   NN3506    common
  19      5691424         .        19p13.3                    RPL36                    NON SYNONYMOUS CODING   NN3538     novel
  19      8191184    rs35025963    19p13.2                     FBN3                    NON SYNONYMOUS CODING   NN1075    common
  19     17660300    rs11666267    19p13.11                  FAM129C                   NON SYNONYMOUS CODING   1659F     common

###### Genes with hits in at least two categories of variants found from Brazilian samples exome and from public data.

  Gene                                                                            public CNVs   public SNPs   exome CNVs   exome SNVs     band     reference
  ------------------------------------------------------------------------------ ------------- ------------- ------------ ------------ ---------- -----------
  ACOXL (acyl-CoA oxidase-like)                                                       no            no            no          sv2c        2q13      [@b59]
  ACSM1 (acyl-CoA synthetase medium-chain family member 1)                            no            no            no          2vsc      16p12.3     [@b60]
  ANKRD42 (ankyrin repeat domain 42)                                                  no            no            no          sv2c      11q14.1         
  CNGB3 (cyclic nucleotide gated channel beta 3)                                      yes           no            no          yes        8q21.3         
  CYFIP2 (cytoplasmic FMR1 interacting protein 2)                                     no            no            no          sv2c       5q33.3     [@b61]
  CYP19A1 (cytochrome P450, family 19, subfamily A, polypeptide 1)                    yes           no            no          yes       15q21.2         
  DDX60 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 60)                                   yes           no            no          yes        4q32.3         
  DNAH3 (dynein, axonemal, heavy chain 3)                                             no            no            no          sv2c      16p12.3         
  DNHD1 (dynein heavy chain domain 1)                                                 yes           no            no          yes       11p15.4         
  EMP2 (epithelial membrane protein 2)                                                yes           yes           no           no       16p13.13    [@b62]
  GIMAP6 (GTPase, IMAP family member 6)                                               no            no            no          2vsc       7q36.1         
  GOLGA8DP (golgin A8 family, member D, pseudogene)                                   yes           no           yes           no       15q11.2         
  HEATR1 (HEAT repeat containing 1)                                                   yes           no            no          yes         1q43          
  IFLTD1 (lamin tail domain containing 1)                                             no            no            no          3vsc      12p12.1         
  ILDR1 (immunoglobulin-like domain containing receptor 1)                            no            no            no          2vsc      3q13.33         
  ITGA3 (integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor))        yes           no            no          yes       17q21.33        
  MSR1 (macrophage scavenger receptor 1)                                              no            no            no          sv2c        8p22          
  MUC6 (mucin 6, oligomeric mucus/gel-forming)                                        no            no            no          2vsc      11p15.5         
  NPSR1 (neuropeptide S receptor 1)                                                   no            no            no          sv2c       7p14.3         
  OBSL1 (obscurin-like 1)                                                             no            no            no          sv2c        2q35          
  OR8K3 (olfactory receptor, family 8, subfamily K, member 3)                         yes           no            no          yes       11q12.1         
  PPP6R3 (protein phosphatase 6, regulatory subunit 3)                                yes           no            no          yes       11q13.2         
  RGS12 (regulator of G-protein signaling 12)                                         no            no            no          2vsc       4p16.3     [@b63]
  SDK1 (sidekick cell adhesion molecule 1)                                            yes           no            no          yes        7p22.2         
  SMYD3 (SET and MYND domain containing 3)                                            yes           no            no          yes         1q44          
  TRIM22 (tripartite motif containing 22)                                             yes           no            no          yes       11p15.4         
  TRIM48 (tripartite motif containing 48)                                             no            no           sv2c          no        11q11          
  TRIML2 (tripartite motif family-like 2)                                             yes           no            no          yes        4q35.2         
  UQCRC2 (ubiquinol-cytochrome c reductase core protein II)                           yes           no            no          yes       16p12.2     [@b56]
  VWDE (von Willebrand factor D and EGF domains)                                      no            no            no          2vsc       7p21.3         

The type of analysis is highlighted with a grey background. All genes are protein coding. The only exception is GOLGA8DP, which is a transcribed unprocessed pseudogene, and OR8K3, which is a polymorphic pseudogene. Legend: sv2c: same variant in 2 children; 2vsc: 2 variants in the same child. In the last column we could observe references of association of the gene and other neurodevelopment disorder.

###### KEGG pathways significant after Bonferroni Correction using STRING.

  GO id   Term                                    no. of genes    p-value    p-value Bonferroni
  ------- -------------------------------------- -------------- ----------- --------------------
  4810    Regulation of actin cytoskeleton             11        6.59E--09       1.89E--06
  4730    Long--term depression                        7         1.42E--08       4.07E--06
  4915    Estrogen signaling pathway                   8         1.92E--08       5.51E--06
  5016    Huntington's disease                         9         2.83E--07       8.11E--05
  4724    Glutamatergic synapse                        7         1.14E--06       3.28E--04
  4540    Gap junction                                 6         3.46E--06       9.93E--04
  4723    Retrograde endocannabinoid signaling         6         8.07E--06       2.32E--03
  4720    Long--term potentiation                      5         1.49E--05       4.27E--03
  4726    Serotonergic synapse                         6         1.67E--05       4.81E--03
